Navigation Links
EUROPLASMA: Résultats consolidés 2012
Date:9/26/2013

nouveau gazéifieur est en cours de construction pour une remise en route de l'usine début 2014. La nouvelle échéance pour la « Take Over Date » est fixée au 28 février 2014.

Réfection complète du four de traitement des déchets dangereux

Les problèmes techniques rencontrés au niveau de la préparation des charges de la ligne de traitement ont été réglés à la fin du 1er semestre 2013. Ces modifications, couplées à la réfection trisannuelle complète du four menée durant l'été 2013, devraient accélérer les cadences de production. Ces dernières ont déjà retrouvé de bons niveaux avant l'arrêt programmé de l'été 2013, tendance qui doit être confirmée à compter de la reprise de la production fin septembre 2013.

Recentrage du Groupe Europlasma sur son core-business

En complément du nouveau financement et des actions opérationnelles listées ci-avant, plusieurs mesures ont été prises pour assurer le rétablissement du Groupe et recentrer ses activités sur son cœur de métier, et ses technologies brevetées et son savoir-faire.

Ces mesures comprennent la vente d'actifs non stratégiques et l'abandon d'activités non fondamentales, notamment le processus de cession engagé au cours du 1er semestre 2013 du secteur Air & Gaz, détenu à 51%. Plusieurs acheteurs potentiels ont manifesté leur intérêt et la finalisation de l'opération est attendue au cours du 1er semestre 2014.

Par ailleurs, plus de 20 ans après avoir fondé Europlasma, Monsieur Didier Pineau a quitté ses fonctions de directeur général du Groupe fin juin 2013. Monsieur Didier Pineau reste actionnaire du groupe. François Marchal,
'/>"/>

SOURCE Europlasma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Axovant Sciences Ltd. (NYSE:  AXON), a leading ... announced upcoming presentations at three investor conferences: , ... Healthcare Conference in New York at ... at 2:00 PM at the BioCentury NewsMakers Conference in ... & Conference Center , Thursday, September 17 at 9:30 ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 /PRNewswire/ ... has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. ... the pharmaceutical and biotechnology industries is anticipated. ... of drug development - from formulations for ...
(Date:9/2/2015)... ARBOR, Mich. and LIBERTYVILLE, Ill. (PRWEB) , ... ... ... NSF International, a leading provider of regulatory compliance, quality systems, analytical ... Avarent LLC, a consulting firm with expertise in medical device products/processes development, ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... and Companies" to their offering. ... variations, development of sequencing technologies, and their applications. ... well as companies developing them. Various applications of ...
Breaking Biology Technology:Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2
... Webcast Presentation Scheduled for Wednesday, January 14, 2009 at ... Colo. and SAN CARLOS, Calif., Jan. 8 ARCA ... heart failure and other cardiovascular diseases, and Nuvelo, Inc. ... Brewer, ARCA,s president and chief executive officer, will present ...
... Concentric Medical, Inc., the global leader in devices ... that it has completed a $15 million round of ... capital firm New Enterprise Associates, Inc. (NEA) and includes ... Concentric over the last several months made the opportunity ...
... Remote Patient Monitoring Projected to Exceed $8 Billion ... Inc., developer of LifeShirt(R), a continuous, integrated and ... that president and chief executive officer Howard Baker ... January 14, 2009 at the Marines Memorial Club ...
Cached Biology Technology:ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 3ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 4ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 5Concentric Medical Closes on $15 Million Financing 2VivoMetrics to Present at the 2009 Biotech Showcase 2VivoMetrics to Present at the 2009 Biotech Showcase 3
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/3/2015)... JOSE, Calif. , Aug. 3, 2015 ... of human interface solutions, today announced that members of ... community at the Pacific Crest Global Technology Leadership Forum ... Time. The conference will be held at the Sonnenalp ... The presentation may include forward-looking information. An ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... not always show it, but people are rarely born with ... and legs to grow in the right places and point ... between our fingers and toes and every other formative detail ... to construct and position our limbs were being perfected more ...
... one strain of an infectious disease can exist at ... in the August issue of The American Naturalist, Ken ... mathematical model to help explain multiple strains, showing that ... that the coexistence of multiple infectious disease strains result ...
... could peer microscopically into the closest freshwater pond, you'd ... you'd probably notice an oddly furry, pear-shaped organism gliding ... This tiny predator has a big name-- Tetrahymena thermophila ... star organism for research into how cells work. , ...
Cached Biology News:UF scientists discover evolutionary origin of fins, limbs 2UF scientists discover evolutionary origin of fins, limbs 3What's shaped like a pear and has 2 genomes? Check the pond 2What's shaped like a pear and has 2 genomes? Check the pond 3
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... a direct antibiotic-based selection system for recombinant ... survival, eliminating the need for costly color ... close to 100% accuracy in recombinant selection. ... robot colony picking. This cloning kit can ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~32 kDa DNase IIα chain and the ~40 kDa proenzyme. DNase II causes both DNA condensation and DNA fragmentation. ...
Biology Products: